Cargando…

Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation

Combining electrochemotherapy with dendritic cell-based immunotherapy is a promising strategy against human metastatic melanoma that deserves to be clinically assessed. While electrochemotherapy induces a rapid regression of metastases, immunotherapy generates systemic anticancer immunity, contribut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerlini, Gianni, Di Gennaro, Paola, Borgognoni, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Landes Bioscience 2012
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3525636/ https://www.ncbi.nlm.nih.gov/pubmed/23264927 http://dx.doi.org/10.4161/onci.21991

Ejemplares similares

Tolerogenic IDO1(+)CD83(−) Langerhans Cells in Sentinel Lymph Nodes of Patients with Melanoma
por: Gerlini, Gianni, et al.
Publicado: (2022)

Melanoma hijacks plasmacytoid dendritic cells to promote its own progression
por: Aspord, Caroline, et al.
Publicado: (2014)

Type 2 innate lymphoid cells: a novel actor in anti-melanoma immunity
por: Jacquelot, Nicolas, et al.
Publicado: (2021)

The extent to which melanoma alters tissue-resident dendritic cell function correlates with tumorigenicity
por: Hargadon, Kristian Michael
Publicado: (2015)

A(2A) blockade enhances anti-metastatic immune responses
por: Beavis, Paul A, et al.
Publicado: (2013)

BRAF-targeted therapy and immune responses to melanoma
por: Ngiow, Shin Foong, et al.
Publicado: (2013)

Activation of dendritic cells by tumor cell death
por: Cirone, Mara, et al.
Publicado: (2012)

Monocyte-derived dendritic cells: Emerging players in the antitumor immune response
por: Kuhn, Sabine, et al.
Publicado: (2013)

In vivo evidence for dendritic cell lysis by NK cells: Hints on improving cancer vaccines by targeting NK cell activation
por: Ferlazzo, Guido
Publicado: (2012)

FOXO3: A master switch for regulating tolerance and immunity in dendritic cells
por: Watkins, Stephanie K., et al.
Publicado: (2012)

Melanoma immunoediting by NK cells
por: Balsamo, Mirna, et al.
Publicado: (2012)

Exome sequencing in primary melanoma identifies novel drivers of melanoma progression
por: Montagnani, Valentina, et al.
Publicado: (2015)

Immune response markers in sentinel nodes may predict melanoma progression
por: Rodolfo, Monica, et al.
Publicado: (2014)

How melanoma cells inactivate NK cells
por: Pietra, Gabriella, et al.
Publicado: (2012)

Blocking IL-10 enhances bacillus Calmette-Guérin induced T helper Type 1 immune responses and anti-bladder cancer immunity
por: Luo, Yi
Publicado: (2012)

IL15 synergizes with radiotherapy to reprogram the tumor immune contexture through a dendritic cell connection
por: Pilones, Karsten A., et al.
Publicado: (2020)

Good things come in small packages: Therapeutic anti-tumor immunity induced by microRNA nanoparticles
por: Cubillos-Ruiz, Juan R., et al.
Publicado: (2012)

Evidence of synergy with combined BRAF-targeted therapy and immune checkpoint blockade for metastatic melanoma
por: Cooper, Zachary A, et al.
Publicado: (2014)

Immune mediated mechanisms of melanocyte destruction: Paving the way for efficient immunotherapeutic strategies against melanoma
por: Speeckaert, Reinhart, et al.
Publicado: (2012)

Tumors induce immune tolerance through activation of β-catenin/TCF4 signaling in dendritic cells: A novel therapeutic target for cancer immunotherapy
por: Suryawanshi, Amol, et al.
Publicado: (2015)

Identification of human inflammatory dendritic cells
por: Segura, Elodie, et al.
Publicado: (2013)

Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cells
por: Larmonier, Nicolas, et al.
Publicado: (2012)

Importance of helper T-cell activation in dendritic cell-based anticancer immunotherapy
por: Schreibelt, Gerty, et al.
Publicado: (2013)

Host CD73 impairs anti-tumor immunity
por: Salmi, Marko, et al.
Publicado: (2012)

A novel role for granzymes in anti-tumor immunity
por: Hoves, Sabine, et al.
Publicado: (2012)

"Flagellated" cancer cells propel anti-tumor immunity
por: Garaude, Johan, et al.
Publicado: (2012)

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy
por: Grimaldi, Antonio M, et al.
Publicado: (2014)

Intratumoral alterations of dendritic-cell differentiation and CD8(+) T-cell anergy are immune escape mechanisms of clear cell renal cell carcinoma
por: Noessner, Elfriede, et al.
Publicado: (2012)

IL-10 control of dendritic cells in the skin
por: Clausen, Björn E., et al.
Publicado: (2013)

Dendritic cell-based immunotherapy in ovarian cancer
por: Coosemans, An, et al.
Publicado: (2013)

Small extracellular vesicles: multi-faceted tools for leukemia immune evasion in vivo
por: Gargiulo, Ernesto, et al.
Publicado: (2022)

ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013)

Attenuated measles virus used as an oncolytic virus activates myeloid and plasmacytoid dendritic cells
por: Fonteneau, Jean-François, et al.
Publicado: (2013)

Targeting dendritic cells in situ for breast cancer immunotherapy
por: Wang, Bei
Publicado: (2012)

Naturally circulating dendritic cells to vaccinate cancer patients
por: Bol, Kalijn F., et al.
Publicado: (2013)

Zoledronate-pulsed dendritic cell-based anticancer vaccines
por: Kamigaki, Takashi, et al.
Publicado: (2013)

Melanoma metastases caught in the AKT
por: Kircher, David A., et al.
Publicado: (2016)

Distinct anti-tumoral functions of adaptive immune cells in liver cancer
por: Schneider, Carlo, et al.
Publicado: (2012)

Emerging evidence of anti-tumor immune control in the central nervous system
por: Donson, Andrew M., et al.
Publicado: (2012)

Radiation therapy combined with Listeria monocytogenes-based cancer vaccine synergize to enhance tumor control in the B16 melanoma model
por: Lim, Joanne YH, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vnkgajin9c7vqdipklai38dl8n